EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 135 filers reported holding EPIZYME INC in Q2 2019. The put-call ratio across all filers is 1.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $347,000 | -55.7% | 292,102 | +2.5% | 0.00% | – |
| Q4 2021 | $783,000 | -54.3% | 284,858 | -4.7% | 0.00% | -100.0% |
| Q3 2021 | $1,713,000 | -34.4% | 298,892 | -4.9% | 0.00% | 0.0% |
| Q2 2021 | $2,613,000 | -17.5% | 314,412 | -13.5% | 0.00% | 0.0% |
| Q1 2021 | $3,166,000 | -20.3% | 363,460 | -0.6% | 0.00% | 0.0% |
| Q4 2020 | $3,970,000 | -17.9% | 365,556 | -9.8% | 0.00% | -50.0% |
| Q3 2020 | $4,835,000 | -33.5% | 405,301 | -10.5% | 0.00% | -33.3% |
| Q2 2020 | $7,275,000 | +24.2% | 452,989 | +19.9% | 0.00% | 0.0% |
| Q1 2020 | $5,859,000 | -28.3% | 377,766 | +13.8% | 0.00% | 0.0% |
| Q4 2019 | $8,169,000 | +154.7% | 332,049 | +6.8% | 0.00% | +200.0% |
| Q3 2019 | $3,207,000 | -19.0% | 310,935 | -1.5% | 0.00% | -50.0% |
| Q2 2019 | $3,960,000 | – | 315,561 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
| Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
| KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
| Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
| Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
| MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
| Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
| Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
| Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
| Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |